Sign in
8-K

Current Report

Candel Therapeutics, Inc. Filed Acc 0001193125-25-145405

Material agreement · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing